CF
BIOR

Cantor Fitzgerald’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Cantor Fitzgerald’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,640
Closed -$45.4K – 766
2023
Q1 		$45.4K Buy
+1,640
New +$55.6K ﹤0.01% 584

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cantor Fitzgerald's BIOR Position: Q2 2023 in Review

Cantor Fitzgerald sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2023, closing a stake of 1,640 shares — an estimated $45.4K sold.

Cantor Fitzgerald first reported a position in BIOR in Q1 2023 and held it in 1 quarter. The position peaked at $45.4K in Q1 2023. 30 funds tracked by Wall St. Rank hold BIOR as of Q2 2023.

  • Cantor Fitzgerald reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 1,640 Biora Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $45.4K.
  • Cantor Fitzgerald first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Cantor Fitzgerald's Biora Therapeutics, Inc. Common Stock position peaked at $45.4K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.